These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6258451)

  • 1. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats.
    Textor SC; Brunner H; Gavras H
    Am J Physiol; 1981 Feb; 240(2):H255-61. PubMed ID: 6258451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria.
    Nakashima A; Angus JA; Johnston CI
    Eur J Pharmacol; 1982 Jul; 81(3):479-85. PubMed ID: 6749532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm.
    van Dijk MA; Kroon I; Kamper AM; Boomsma F; Danser AH; Chang PC
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):484-90. PubMed ID: 10710136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
    Carvalho MB; Duarte FV; Faria-Silva R; Fauler B; da Mata Machado LT; de Paula RD; Campagnole-Santos MJ; Santos RA
    Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and bradykinin: interactions between two centrally active peptides.
    Lewis RE; Hoffman WE; Phillips MI
    Am J Physiol; 1983 Feb; 244(2):R285-91. PubMed ID: 6337513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of angiotensin III by angiotensin-converting enzyme.
    Chiu AT; Ryan JW; Stewart JM; Dorer FE
    Biochem J; 1976 Apr; 155(1):189-92. PubMed ID: 180981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for the presence of a different converting enzyme in the hamster cheek pouch.
    Cornish KG; Joyner WL; Gilmore JP
    Circ Res; 1979 Apr; 44(4):540-4. PubMed ID: 218748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin I and II and their interactions with some prostanoids in perfused human umbilical arteries.
    Bjøro K
    Prostaglandins; 1985 Dec; 30(6):989-98. PubMed ID: 3911295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of captopril induced hypotension in rats.
    Clarke DE; Wagner LB; Wagner LA
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractile responses of isolated dog mesenteric arteries to angiotensin I, II and III.
    Toda N; Hayashi S; Miyazaki M
    Jpn J Pharmacol; 1978 Aug; 28(4):527-34. PubMed ID: 732038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of captopril on the human foetal placental circulation: an interaction with bradykinin and angiotensin I.
    de Moura R; Lopes MA
    Br J Clin Pharmacol; 1995 May; 39(5):497-501. PubMed ID: 7669485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Hypertension; 1981; 3(2):269-76. PubMed ID: 6260647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats.
    Russell PC; Emery CJ; Cai YN; Barer GR; Howard P
    Eur Respir J; 1990 Jul; 3(7):779-85. PubMed ID: 2261965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
    Gorelik G; Carbini LA; Scicli AG
    J Pharmacol Exp Ther; 1998 Jul; 286(1):403-10. PubMed ID: 9655885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.